Evidence map›Paper›PMID 33453998›Full record

ArticleThe Journal of biological chemistry2020

Hepatocyte nuclear factor 1β suppresses canonical Wnt signaling through transcriptional repression of lymphoid enhancer-binding factor 1.

Siu Chiu Chan, Sachin S Hajarnis, Sophia M Vrba, Vishal Patel, Peter Igarashi

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Siu Chiu ChanDepartment of Medicine, University of Minnesota Medical School, Minneapolis, Minnesota, USA.
Sachin S HajarnisDepartment of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Sophia M VrbaDepartment of Medicine, University of Minnesota Medical School, Minneapolis, Minnesota, USA.
Vishal PatelDepartment of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Peter IgarashiDepartment of Medicine, University of Minnesota Medical School, Minneapolis, Minnesota, USA; Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA. Electronic address: igarashi@umn.edu.
University of Minnesota Medical Center · USThe University of Texas Southwestern Medical Center · US

Funding

REGULATION OF RENAL NA+/H+ EXCHANGER GENE EXPRESSIONR01DK042921 · NIDDK · YALE UNIVERSITY · PI IGARASHI, PETER · 1991 to 2025
$5.1M
Regulation of Kidney-Specific Gene ExpressionR37DK042921 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI IGARASHI, PETER · 2011 to 2020
$3.6M
The impact of RNA chemical modifications on polycystic kidney disease progressionR01DK102572 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI PATEL, VISHAL · 2015 to 2024
$3.5M
NIDDK NIH HHS R01 DK042921NIDDK NIH HHS R01 DK102572NIDDK NIH HHS R37 DK042921
6 · The paper itself

Abstract

Hepatocyte nuclear factor-1β (HNF-1β) is a tissue-specific transcription factor that is required for normal kidney development and renal epithelial differentiation. Mutations of HNF-1β produce congenital kidney abnormalities and inherited renal tubulopathies. Here, we show that ablation of HNF-1β in mIMCD3 renal epithelial cells results in activation of β-catenin and increased expression of lymphoid enhancer-binding factor 1 (LEF1), a downstream effector in the canonical Wnt signaling pathway. Increased expression and nuclear localization of LEF1 are also observed in cystic kidneys from Hnf1b mutant mice. Expression of dominant-negative mutant HNF-1β in mIMCD3 cells produces hyperresponsiveness to exogenous Wnt ligands, which is inhibited by siRNA-mediated knockdown of Lef1. WT HNF-1β binds to two evolutionarily conserved sites located 94 and 30 kb from the mouse Lef1 promoter. Ablation of HNF-1β decreases H3K27 trimethylation repressive marks and increases β-catenin occupancy at a site 4 kb upstream to Lef1. Mechanistically, WT HNF-1β recruits the polycomb-repressive complex 2 that catalyzes H3K27 trimethylation. Deletion of the β-catenin-binding domain of LEF1 in HNF-1β-deficient cells abolishes the increase in Lef1 transcription and decreases the expression of downstream Wnt target genes. The canonical Wnt target gene, Axin2, is also a direct transcriptional target of HNF-1β through binding to negative regulatory elements in the gene promoter. These findings demonstrate that HNF-1β regulates canonical Wnt target genes through long-range effects on histone methylation at Wnt enhancers and reveal a new mode of active transcriptional repression by HNF-1β.

Indexed as

Wnt Signaling PathwayAnimalsAxin Proteinbeta CateninBinding SitesEpithelial CellsGene Expression RegulationHepatocyte Nuclear Factor 1-betaHistonesKidneyLymphoid Enhancer-Binding Factor 1MethylationMiceMice, KnockoutMutagenesisPromoter Regions, GeneticAxin2 protein, mouseAxin Proteinbeta CateninHepatocyte Nuclear Factor 1-betaHistonesLymphoid Enhancer-Binding Factor 1RNA, Small InterferingWnt3A Proteinbeta-catenin (B-catenin)cystic kidney diseasehistone methylationHNF-1βkidneyLEF1T-cell factor (TCF)tissue-specific transcription factortranscription repressorWnt pathwayβ-catenin

Identifiers

PMID33453998
PMCPMC7762946
OpenAlexW3092205767

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.